Man Group PLC Molecular Templates, Inc. Transaction History

Man Group PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.27 - $4.13 $296,448 - $539,353	-130,594 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.37 - $6.87 $80,576 - $164,261	23,910 Added 22.41%	130,594 $512,000
Q3 2021 Nov 15, 2021	BUY	$5.78 - $7.86 $134,477 - $182,870	23,266 Added 27.89%	106,684 $716,000
Q2 2021 Aug 16, 2021	SELL	$7.82 - $12.44 $41,516 - $66,043	-5,309 Reduced 5.98%	83,418 $652,000
Q1 2021 May 17, 2021	SELL	$9.33 - $14.05 $116,261 - $175,077	-12,461 Reduced 12.31%	88,727 $1.12 Million
Q4 2020 Feb 16, 2021	BUY	$8.48 - $12.23 $404,021 - $582,686	47,644 Added 88.98%	101,188 $950,000
Q3 2020 Nov 16, 2020	BUY	$9.99 - $14.41 $209,030 - $301,514	20,924 Added 64.14%	53,544 $585,000
Q2 2020 Aug 14, 2020	BUY	$12.28 - $17.63 $228,788 - $328,464	18,631 Added 133.18%	32,620 $450,000
Q1 2020 May 15, 2020	SELL	$11.31 - $18.26 $1.21 Million - $1.96 Million	-107,287 Reduced 88.47%	13,989 $186,000
Q4 2019 Feb 18, 2020	BUY	$6.44 - $14.21 $781,017 - $1.72 Million	121,276 New	121,276 $1.7 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $10.1M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.